Neoadjuvant chemoimmunotherapy may beat immunotherapy alone when it comes to pathologic response, but its impact on survival remains to be seen.

A new report has laid bare how head and neck cancers have "persistently poor" survival rates in our region.

A new wave of immuno-therapies is reshaping the fight against cancer, turning the body’s own immune system into a powerful ...

Head and neck squamous cell carcinomas (HNSCC) are the seventh-most prevalent form of cancer and are associated with human ...

All seven northern Integrated Care Boards have higher rates of head and neck cancer than the England average. Six also have higher death rates, with the North East and North Cumbria the worst in the ...

Mumbai: India is facing a silent cancer crisis, with nearly 60% to 80% of cases being diagnosed only at advanced stages, drastically reducing survival chances. With over 15 lakh new cases reported ...

The research warns that a combination of lifestyle factors, late diagnosis, and the logistical struggle of accessing healthcare is costing lives. | ITV News Granada ...

People in the most socioeconomically deprived areas of the UK are more likely to die from head and neck cancer, more likely to be diagnosed at ...

Head and neck cancer (HNC) represents a significant global health challenge, characterized by aggressive local invasion, frequent recurrence, and poor survival rates. Beyond its physical burden, HNC ...

The two blockbusters have made a big difference in bladder cancer survival, but will their chemistry hold up when tested in other types?

Bicara Therapeutics (NASDAQ:BCAX) outlined its clinical and development strategy for its lead bifunctional antibody program, FICERA, during a presentation and fireside chat at TD Cowen’s 46th annual ...

Restoring natural vocal cord vibrations may reduce aggressive cancer activity, offering new clues about how laryngeal cancer develops.